-

Shareholder Alert: Robbins LLP Announces Insperity, Inc. (NSP) Accused of Misleading Shareholders

SAN DIEGO, Calif. & KINGWOOD, Texas--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP announces that a purchaser of Insperity, Inc. (NYSE: NSP) filed a class action complaint against the Company for alleged violations of the Securities Exchange Act of 1934 between February 11, 2019 and February 11, 2020. Insperity provides human resources, employee benefits, and business solutions services to small and medium-sized businesses.

If you suffered a loss as a result of Insperity's misconduct, click here.

Insperity, Inc. (NSP) Accused of Misleading Shareholders

According to the complaint, in February 2019, Insperity reported its fourth quarter and full year 2018 financials that touted significant year-over-year growth. Then, in April 2019, Insperity lauded "record" first quarter 2019 results and raised its ambitious full-year 2019 guidance. As a result of its auspicious financial reports and the implied success of its business model, Insperirty's stock price increased dramatically during the first half of 2019. Despite its previous positive financials, in July 2019, Insperity offered disappointing third quarter 2019 guidance and reduced its full-year 2019 guidance, citing an anomalous increase in large medical claim costs. Then, in November 2019, Insperity released third quarter 2019 results that significantly missed analysts' estimates and were materially down year-over-year, once again citing the large medical claim costs that Insperity continued to assure were an anomaly. Finally, on February 11, 2020, Insperity revealed for the third time that large medical claims had negatively impacted the Company and offered a lackluster guidance for first quarter and full-year 2020. Consequently, analysts lowered their views on Insperity stock stating "after three quarters, rising jumbo claims appear to be a trend, not aberrational." On this news, Insperity's share price fell $17.44 per share, or 20%, to close at $70.71 per share.

Insperity, Inc. (NSP) Shareholders Have Options

Contact us to learn more:
Lauren Levi
(800) 350-6003
llevi@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. To be notified if a class action against Insperity settles or to receive free alerts about companies engaged in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Lauren Levi
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
llevi@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Snowflake Inc. Class Action Reminder - Robbins LLP Encourages SNOW Stockholders to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Snowflake Inc. (NYSE: SNOW) Class A common stock between June 27, 2023 and February 28, 2024. Snowflake is a software company that provides cloud data storage that enables customers to consolidate data onto data-driven applications and share data for the purpose of running analytics and other processes. For more information, submit a form, ema...

Corcept Therapeutics Incorporated Class Action Reminder – Robbins LLP Encourages CORT Stockholders to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Corcept Therapeutics Incorporated (NASDAQ: CORT) common stock between October 31, 2024 and December 30, 2025. Corcept is a pharmaceutical company focused on the development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol.For more information, submit a...

uniQure N.V. Class Action Reminder – Robbins LLP Encourages QURE Stockholders to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired uniQure N.V. (NASDAQ: QURE) ordinary shares between September 24, 2025 and October 31, 2025. uniQure is a biotechnology company developing gene therapies for rare diseases.For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.What is the class period? September 24, 2025 – October 31, 2025What...
Back to Newsroom